The CCA1 antibody was generated using recombinant CCA1 protein or specific peptide sequences as immunogens. Key validation steps include:
Specificity: Confirmed reactivity with Arabidopsis thaliana CCA1 (~80 kDa), but not with orthologs in Oryza sativa (rice) or Solanum lycopersicum (tomato) .
Applications:
In Western blots, a 1:500 dilution of the antibody detected CCA1 in nuclear extracts of Arabidopsis wild-type plants but not in cca1/lhy/toc1 mutants .
Batch-dependent variability was observed, with some antibody lots failing to detect SUMO-conjugated CCA1 .
DNA-Binding Activity: CCA1 antibody confirmed CCA1’s role in binding light-responsive promoters (e.g., Lhcb13*) via EMSA, with loss of binding in cca1-1 mutants .
ChIP-Seq Analysis: Identified >1,000 CCA1 target genes enriched for circadian outputs, stress responses, and metabolic pathways .
Sumoylation: Immunoprecipitation with CCA1 antibody revealed rhythmic sumoylation of CCA1 under light-dark cycles, impacting its transcriptional activity .
Phosphorylation: CCA1’s interaction with Casein Kinase 2 (CK2) was validated using phospho-specific antibodies, linking hyperphosphorylation to altered circadian periods .
Heterosis in Defense: CCA1 antibody-based assays showed CCA1’s role in enhancing pathogen defense in hybrid plants by modulating salicylic acid levels .
Leaf Senescence: ChIP-qPCR demonstrated CCA1 binding to promoters of senescence-related genes (ORE1, GLK2), delaying aging in Arabidopsis .
Core Circadian Feedback Loop: CCA1 antibody confirmed CCA1’s repression of evening-phased genes (e.g., TOC1) and activation of morning-phased genes (e.g., PRR9) .
Light Signaling: Demonstrated CCA1’s role in phytochrome-mediated gene regulation, with loss of CCA1 disrupting light-induced Lhcb expression .
Epigenetic Regulation: ChIP-Seq revealed CCA1 occupancy at non-cycling genes, expanding its role beyond circadian outputs .
Species Specificity: Limited to Arabidopsis thaliana, restricting cross-species studies .
Batch Variability: Some antibody lots showed reduced efficacy in detecting SUMO-modified CCA1 .
Interference in Mutants: Use in cca1/lhy double mutants requires validation due to partial functional redundancy .
| Modification | Functional Impact | Detection Method |
|---|---|---|
| Phosphorylation | Alters dimerization and DNA-binding affinity | WB with phospho-antibodies |
| Sumoylation | Modulates transcriptional repression | IP with anti-SUMO1/2 |
| Ubiquitination | Regulates protein turnover | IP with anti-ubiquitin |
KEGG: sce:YER168C
STRING: 4932.YER168C
CCA1 is a MYB-related transcription factor that serves as a core component of the circadian clock in plants, particularly well-studied in the model organism Arabidopsis thaliana. It plays a crucial role in regulating the expression of numerous clock-controlled genes that influence almost every aspect of plant growth and development, including responses to biotic and abiotic stresses. The circadian clock in plants functions as an endogenous time-keeping mechanism that allows organisms to coordinate biological processes with specific times of day, optimizing their physiology to match environmental conditions . CCA1 antibodies enable researchers to study the temporal and spatial dynamics of this key regulatory protein, its post-translational modifications, protein-protein interactions, and DNA-binding properties. These antibodies have been instrumental in mapping the genome-wide targets of CCA1, revealing its broad regulatory role beyond core clock function .
The use of CCA1 antibodies has significantly expanded our understanding of how the molecular oscillator connects to downstream clock-regulated outputs. Through techniques such as chromatin immunoprecipitation followed by sequencing (ChIP-Seq), researchers have identified direct targets of CCA1 throughout the genome, establishing mechanistic links between the circadian clock and various biological processes . Additionally, antibodies against CCA1 have enabled studies of its post-translational regulation, particularly phosphorylation by protein kinase CK2, which modulates CCA1's DNA-binding and transcriptional regulatory activities .
CCA1 antibodies serve as versatile tools in multiple experimental techniques that are essential for circadian biology research. Chromatin immunoprecipitation (ChIP) approaches using CCA1 antibodies have been particularly valuable for identifying direct targets of CCA1 throughout the genome. These experiments typically involve crosslinking proteins to DNA, fragmenting chromatin, immunoprecipitating CCA1-bound chromatin fragments with specific antibodies, and analyzing the associated DNA sequences. When coupled with high-throughput sequencing (ChIP-Seq), this approach has revealed thousands of CCA1-occupied sites in the Arabidopsis genome under different environmental conditions . The comprehensive identification of CCA1 targets through this method has significantly expanded our understanding of the breadth of processes regulated by the circadian clock.
Co-immunoprecipitation (Co-IP) assays using CCA1 antibodies have been instrumental in identifying protein-protein interactions involving CCA1. For instance, researchers have used this approach to demonstrate that CCA1 physically interacts with protein kinase CK2 regulatory subunits like CKB4 . These experiments typically involve immunoprecipitating CCA1 with a specific antibody (e.g., anti-GFP for CCA1-YFP fusion proteins) and then detecting interacting proteins using antibodies against the partner protein or tag (e.g., anti-MYC for CKB4-MYC). Western blotting with CCA1 antibodies allows researchers to monitor CCA1 protein abundance throughout the circadian cycle and assess its post-translational modifications such as phosphorylation. This approach has been crucial for understanding how CCA1 is regulated at the protein level . Additionally, immunofluorescence microscopy with CCA1 antibodies enables visualization of CCA1's subcellular localization and can be combined with fluorescently tagged interaction partners to study protein complexes in vivo.
Successful ChIP-Seq experiments with CCA1 antibodies require careful consideration of temporal, experimental, and analytical factors. Since CCA1 expression and activity follow a circadian rhythm, with peak expression occurring around dawn, sample collection timing is critical. Research has shown that for CCA1 ChIP-Seq, plant samples should ideally be collected at zeitgeber time (ZT) 26 (2 hours after subjective dawn on the second day in continuous light), when CCA1 protein levels are high . This timing maximizes the signal-to-noise ratio and increases the likelihood of detecting genuine CCA1 binding events. As a negative control, samples can be collected at ZT38 (evening time point) when CCA1 protein levels are naturally very low . This temporal control helps distinguish authentic binding sites from experimental artifacts.
The choice of CCA1 antibody significantly impacts ChIP-Seq results. Many researchers have successfully used plants expressing epitope-tagged CCA1 (e.g., CCA1-GFP driven by the endogenous CCA1 promoter) and performed immunoprecipitation with antibodies against the tag . This approach minimizes background issues that can arise with antibodies directly against CCA1. For peak identification, multiple independent biological replicates are essential—successful studies have typically used at least three independent ChIP-Seq experiments with strong correlation between replicates . Peak calling should employ specialized software such as HOMER combined with irreproducible discovery rate (IDR) analysis to identify high-confidence binding sites . Additional methodological considerations include thorough sonication optimization to achieve chromatin fragments of 200-300 bp, rigorous washing steps to reduce background, and inclusion of input DNA controls for normalizing ChIP-Seq signals during data analysis.
Distinguishing between phosphorylated and non-phosphorylated forms of CCA1 is crucial for understanding its functional regulation, as phosphorylation by protein kinase CK2 significantly impacts CCA1's DNA-binding ability and transcriptional regulatory function. Two-dimensional protein gel electrophoresis combined with immunoblotting has proven effective for separating CCA1 isoforms with different phosphorylation states. This technique separates proteins first by isoelectric point and then by molecular weight, allowing visualization of multiple CCA1 phosphorylated forms that appear as a series of spots with progressively lower isoelectric points . Research has shown that overexpression of the CK2 regulatory subunit CKB4 enriches CCA1 spots with lower isoelectric points, corresponding to more heavily phosphorylated CCA1 isoforms .
Immunoprecipitation of CCA1 followed by detection with phospho-specific antibodies (such as anti-phosphoserine antibodies) provides another approach to assess CCA1 phosphorylation status. Studies have demonstrated that this approach can reveal differences in CCA1 phosphorylation patterns under various conditions, such as between plants with different CK2 activity levels . For investigating which phosphorylation state of CCA1 preferentially binds to target promoters, researchers have successfully employed double ChIP assays. This sophisticated approach involves a first round of immunoprecipitation with anti-CCA1 (or anti-tag) antibodies to pull down all CCA1 bound to chromatin, followed by a second round of immunoprecipitation with anti-phosphoserine antibodies to specifically isolate the phosphorylated fraction . This method has revealed that dephosphorylated CCA1 isoforms preferentially bind to the promoters of oscillator genes . Additionally, pharmacological approaches using CK2 inhibitors (such as DRB) or genetic approaches with inducible dominant-negative CK2 constructs can help assess the functional consequences of altered CCA1 phosphorylation states on target gene expression and circadian rhythms.
Temperature significantly influences circadian clock function, and CCA1 antibodies provide valuable tools for investigating the molecular mechanisms underlying temperature compensation and entrainment. ChIP assays using CCA1 antibodies at different ambient temperatures (e.g., 12°C, 22°C, and 27°C) can reveal temperature-dependent changes in CCA1's DNA-binding patterns to target promoters. Research has shown that temperature affects CCA1 binding to the promoters of core oscillator genes such as TOC1, LUX, PRR7, and PRR9 . These experiments typically involve growing plants at a standard temperature (e.g., 22°C), transferring them to different temperatures, and then performing ChIP at specific time points to assess CCA1 occupancy at target promoters.
To understand the molecular basis for temperature-dependent changes in CCA1 function, researchers have used immunoprecipitation with CCA1 antibodies followed by detection with phospho-specific antibodies. This approach has revealed that temperature affects the phosphorylation status of CCA1, with potential implications for its activity . Western blotting with CCA1 antibodies at different temperatures can demonstrate how temperature affects CCA1 protein abundance and stability throughout the day. These experiments have shown that the interplay between CCA1 and its regulatory kinase CK2 is temperature-sensitive, with important consequences for clock function at different temperatures .
Functional studies combining CCA1 antibody-based approaches with reporter gene assays (e.g., TOC1:LUC) in wild-type and clock mutant backgrounds (e.g., cca1-1/lhy-11) at different temperatures have demonstrated the critical role of CCA1 in temperature compensation of the circadian clock . These multifaceted approaches using CCA1 antibodies have established a model where two opposing and temperature-dependent activities (CCA1 and CK2) are essential for clock temperature compensation . The model suggests that at higher temperatures, increased CK2 activity leads to greater CCA1 phosphorylation, reducing its DNA-binding capacity and allowing the clock to maintain relatively stable periodicity despite temperature changes.
Several biological and experimental factors can influence the performance of CCA1 antibodies in ChIP experiments, leading to variable results. The circadian regulation of CCA1 expression represents a primary source of variability, as CCA1 protein levels fluctuate dramatically throughout the day, peaking around dawn and reaching minimal levels in the evening . Consequently, ChIP experiments performed at different times of day will yield vastly different results, with optimal signal typically achieved when samples are collected around ZT0-ZT3 (dawn to early morning). Growth conditions significantly impact CCA1 expression and activity, with differences observed between plants grown in light/dark cycles versus continuous light, and between different photoperiods . Temperature also affects CCA1 levels and function, with studies showing temperature-dependent changes in CCA1 binding to target promoters .
Post-translational modifications, particularly phosphorylation by protein kinase CK2, alter CCA1's DNA-binding affinity and therefore impact ChIP results. Research has demonstrated that phosphorylated CCA1 shows reduced DNA-binding capacity compared to dephosphorylated forms . The presence of competing or cooperating transcription factors at CCA1 target promoters can influence CCA1 binding and antibody accessibility. Technical factors such as crosslinking efficiency, sonication conditions, antibody quality and specificity, washing stringency, and chromatin input amount all contribute to variability in ChIP results. To minimize variability, researchers should standardize sample collection times, growth conditions, and experimental protocols; include appropriate controls (e.g., input DNA, IgG controls, known positive and negative target regions); perform multiple biological replicates; and validate key findings using complementary approaches such as electrophoretic mobility shift assays (EMSAs) or reporter gene assays.
Interpreting unexpected or seemingly contradictory ChIP-Seq results for CCA1 binding requires careful consideration of multiple biological and technical factors. The dual function of CCA1 as both a repressor and activator of gene expression depending on the target and context can lead to apparently conflicting results when comparing binding data with expression analyses. For instance, CCA1 binding has been observed not only at evening-expressed genes containing Evening Elements (EE) as expected, but surprisingly also at many morning-expressed genes and genes that do not show circadian oscillation . These unexpected binding patterns suggest more complex regulatory roles for CCA1 than initially understood.
The phosphorylation state of CCA1 significantly impacts its DNA-binding capacity, with research showing that dephosphorylated CCA1 isoforms preferentially bind to target promoters . Therefore, variations in CCA1 phosphorylation under different experimental conditions can lead to apparently contradictory binding results. CCA1 often functions in protein complexes with other clock components and transcription factors, and these interactions can modify its binding specificity and transcriptional activity. The abundance of different interaction partners may vary across conditions, leading to context-dependent binding patterns. The presence of multiple circadian-associated motifs in promoters (e.g., Evening Element, PBX element, G-box) with different affinities for CCA1 adds another layer of complexity . Some binding events observed in ChIP-Seq may not have functional consequences for gene expression, representing what could be considered "exploratory binding" or binding events that require additional signals or partners to influence transcription.
To reconcile contradictory results, researchers should integrate ChIP-Seq data with functional assays such as gene expression analysis in CCA1 mutants (cca1-1) and overexpression lines (CCA1-OX), reporter gene assays, and protein-protein interaction studies. Additionally, comparing binding patterns across different environmental conditions (e.g., light/dark cycles vs. continuous light) and examining the temporal dynamics of binding throughout the circadian cycle can provide valuable context for interpreting unexpected results .
Designing robust experiments to compare CCA1 binding across different environmental conditions requires careful consideration of multiple factors to ensure meaningful comparisons. When investigating light regime effects (e.g., light/dark cycles vs. continuous light), plants should first be entrained under consistent light/dark cycles (typically 12h:12h) before transfer to experimental conditions. Research has shown that CCA1 binding patterns differ between plants in light/dark cycles versus continuous light, with some targets only identified in one condition . For each condition, samples should be collected at multiple time points across the circadian cycle, particularly focusing on the morning hours when CCA1 levels peak. At minimum, collect samples at ZT0-3 (dawn/early morning) when CCA1 protein is abundant and at ZT12-15 (evening) as a negative control when CCA1 levels are low .
Temperature effects on CCA1 binding should be examined by growing plants at a standard temperature (e.g., 22°C) for entrainment, then transferring to experimental temperatures (e.g., 12°C, 27°C) for at least 24-48 hours before sample collection to allow for acclimation . For stress response studies, researchers should establish appropriate stress application protocols that don't disrupt the circadian rhythm itself, typically applying stress treatments after entrainment and monitoring both CCA1 binding and expression of known CCA1 targets involved in stress responses (e.g., COR27, CAT3, ZAT12, DREB2C) . Experimental controls are crucial and should include input DNA samples for normalization, IgG controls to assess non-specific binding, known positive control regions (e.g., TOC1 promoter), and negative control regions where CCA1 doesn't bind.
Studying CCA1 phosphorylation requires rigorous controls to ensure reliable interpretation of results, particularly given the dynamic nature of this post-translational modification. Temporal controls are essential since CCA1 expression and phosphorylation vary throughout the day. Samples should be collected at multiple time points, particularly comparing morning (when CCA1 is abundant) and evening (when CCA1 levels are low) . Genetic controls should include wild-type plants alongside mutants or transgenic lines with altered CCA1 phosphorylation status. These may include CK2 regulatory subunit overexpression lines (e.g., CKB4-MYC-ox) which increase CCA1 phosphorylation, inducible dominant-negative CK2 alpha subunit lines (CKA3-) which reduce CCA1 phosphorylation, and CCA1 phosphorylation site mutants if available .
Pharmacological controls involving CK2 inhibitors such as DRB (5,6-dichloro-1-β-D-ribofuranosylbenzimidazole) provide a complementary approach to genetic manipulation of CCA1 phosphorylation. Research has shown that treatment with 150 μM DRB significantly reduces CCA1 phosphorylation and affects CCA1-regulated gene expression . Technical controls for phosphorylation detection should include lambda phosphatase treatment of some samples to remove phosphate groups as a negative control for phospho-specific antibody detection. For two-dimensional gel electrophoresis approaches, isoelectric focusing standards should be included to accurately identify shifts in isoelectric point corresponding to different phosphorylation states .
When performing co-immunoprecipitation experiments to study CCA1-CK2 interactions, single transgenic lines expressing only one of the tagged proteins serve as specificity controls to ensure that detection of the interaction partner is not due to antibody cross-reactivity . For functional assays assessing the impact of CCA1 phosphorylation on target gene expression, reporter genes such as TOC1:LUC in various genetic backgrounds (e.g., wild-type, cca1 mutants, CK2 mutants) and under different phosphorylation-modulating treatments provide valuable readouts . Temperature controls may also be relevant, as research has shown that temperature affects the balance between CCA1 and CK2 activities, potentially through effects on CCA1 phosphorylation .
The differential binding of CCA1 to both morning-phased and evening-phased genes represents one of the more intriguing aspects of CCA1 function and requires careful interpretation. Genome-wide ChIP-Seq studies have revealed that while CCA1 occupies the promoters of evening-expressed genes containing Evening Elements (EE) as expected based on its known repressor function, it surprisingly also binds to many morning-expressed genes . This seemingly contradictory binding pattern suggests dual roles for CCA1 as both a repressor and activator depending on the target context. The binding to evening-phased genes containing the Evening Element (EE, AAAATATCT) aligns with CCA1's established function as a repressor of evening-expressed clock genes. ChIP-Seq data show that CCA1 binding at these promoters peaks in the morning, when CCA1 protein is abundant, resulting in repression of these evening-phased genes during the day .
In contrast, CCA1 binding to morning-phased genes suggests a potential activator role that has been less well characterized. Analysis of the promoters of CCA1-bound morning-expressed genes revealed different enriched motifs compared to evening-expressed targets, including G-box-like elements, suggesting that CCA1 may be recruited to these promoters through different mechanisms or co-factors . About 40% of rhythmically expressed CCA1 targets identified in light/dark conditions showed peak expression in the morning (ZT22-ZT4), challenging the simple view of CCA1 as predominantly a repressor of evening genes . This dual binding pattern likely reflects the complex network architecture required for generating proper circadian rhythms, where transcription factors may have context-dependent functions.
The temporal dynamics of CCA1 binding and its relationship with target gene expression provide important clues to its regulatory mechanism. CCA1 binding to evening-phased genes in the morning coincides with their repression, while binding to morning-phased genes occurs around the time of their peak expression, consistent with potential activating functions . The phosphorylation state of CCA1 may differentially affect its binding to morning versus evening targets, as research has shown that phosphorylation by CK2 reduces CCA1's DNA-binding capacity . Functional validation through analysis of target gene expression in CCA1 mutants (cca1-1) and overexpression lines (CCA1-OX) confirms that CCA1 indeed regulates both morning and evening-phased genes, though potentially through different mechanisms .
| Target Gene Category | Examples | Peak Expression Time | Enriched Motifs | CCA1 Function |
|---|---|---|---|---|
| Evening-phased genes | TOC1, LUX | ZT10-ZT14 | Evening Element (AAAATATCT) | Repressor |
| Morning-phased genes | LHY, COR27 | ZT22-ZT4 | G-box-like motifs | Potential activator |
| Non-cycling genes | Various stress response genes | N/A | Mixed motifs | Context-dependent |
Motif enrichment analysis is crucial for CCA1 ChIP-Seq data interpretation, as it reveals the DNA sequence elements associated with CCA1 binding. For CCA1, the Evening Element (EE, AAAATATCT) is typically the top enriched motif, though other circadian-associated motifs such as the PBX element (GGGCCCA) and G-box (CACGTG) are also commonly found . The positional distribution of motifs relative to peak centers can provide insights into direct versus indirect binding—for example, EE motifs are typically centered within CCA1 ChIP-Seq peaks, suggesting direct binding . Integrating ChIP-Seq data with gene expression data, particularly time-course expression data from similar conditions, allows classification of targets based on their expression patterns (e.g., morning-phased, evening-phased, non-cycling) and helps in understanding the regulatory consequences of CCA1 binding .
Comparative analysis between different conditions (e.g., LL vs. LD, different temperatures) can reveal condition-specific binding patterns. Researchers have found that while there is substantial overlap between CCA1 targets identified in continuous light versus light/dark cycles, there are also condition-specific targets . Gene Ontology (GO) enrichment analysis of CCA1 targets helps identify the biological processes regulated by CCA1, revealing its role beyond core clock function in processes such as stress responses, hormone signaling, and metabolism . Network analysis integrating CCA1 binding data with other circadian clock components can provide a systems-level understanding of clock function. Visualization tools such as the Integrated Genome Browser (IGB) and AnnoJ browser have been used to make CCA1 ChIP-Seq data accessible to the research community . These resources allow researchers to browse potential CCA1 peaks near their genes of interest and integrate this information with other genomic data.
| Analytical Step | Recommended Approach | Key Considerations |
|---|---|---|
| Peak calling | HOMER with IDR analysis | Use multiple biological replicates (≥3) |
| Target assignment | Assign genes within 1kb of peaks | Consider bidirectional promoters |
| Motif analysis | HOMER, MEME suite | Look for EE, PBX, G-box motifs |
| Expression integration | Correlate binding with time-course data | Classify targets by phase of expression |
| Functional analysis | GO enrichment, pathway analysis | Identify biological processes regulated by CCA1 |
By employing these comprehensive analytical approaches, researchers can extract maximum biological insight from CCA1 ChIP-Seq data and contribute to our understanding of circadian clock function in plants.